{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/17856-0312#drug","name":"GAVILAX","alternateName":"Polyethylene Glycol 3350","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"17856-0312"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA091077"},{"@type":"PropertyValue","propertyID":"UNII","value":"G2M7P15E5P"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"c9688f06-b6db-4afb-b8ff-ef5fb8bf9946"}],"activeIngredient":"POLYETHYLENE GLYCOL 3350","administrationRoute":["ORAL"],"dosageForm":"POWDER, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"ATLANTIC BIOLOGICALS CORP."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN OTC DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA091077","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9688f06-b6db-4afb-b8ff-ef5fb8bf9946","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=17856-0312"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T21:45:43.595Z"}}